[2006] UGSC 17

[2006] UGSC 17

The Supreme Court held that the trademarks 'Rantac' and 'Zantac' are almost identical and their registration in respect of similar pharmaceutical goods is likely to cause confusion or deception among consumers in Uganda. The burden of disproving confusion and deception rested on the appellant, who failed to discharge it. The Court found that the Assistant Registrar and High Court were unduly influenced by an agreement made in India and a Russian decision, both irrelevant to Ugandan law and circumstances. The Court of Appeal properly re-evaluated the evidence and applied the correct legal principles under the Trademarks Act. The appeal to the Supreme Court was a second appeal, not a third,...

Citation
[2006] UGSC 17
Parties
Appellant: J. B. Chemicals & Pharmaceuticals Ltd; Respondent: Glaxo Group Ltd
Court
Supreme Court of Uganda
Jurisdiction
Uganda
Judgment Date
3 October 2006
Procedural Posture
Civil Appeal / Final Judgment in Supreme Court
Outcome
appeal dismissed
Legal Topics
Trademark Registration, Likelihood of Confusion, Burden of Proof, Administrative Tribunal Review
Source Language
English

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 5 Party arguments 2
Sign in to unlock

Parties

J. B. Chemicals & Pharmaceuticals Ltd

Appellant

Glaxo Group Ltd

Respondent

Procedural Posture

Civil Appeal / Final Judgment in Supreme Court

  1. 1 Whether the registration of the trademark 'Rantac' is likely to cause confusion or deception with the respondent's registered trademark 'Zantac'.
  2. 2 Whether the Assistant Registrar of Trademarks properly exercised discretion in allowing the registration of 'Rantac'.
  3. 3 Whether the Court of Appeal correctly re-evaluated the evidence and law regarding similarity and confusion between the trademarks.

Ratio Decidendi

The Supreme Court held that the trademarks 'Rantac' and 'Zantac' are almost identical and their registration in respect of similar pharmaceutical goods is likely to cause confusion or deception among consumers in Uganda. The burden of disproving confusion and deception rested on the appellant, who failed to discharge it. The Court found that the Assistant Registrar and High Court were unduly influenced by an agreement made in India and a Russian decision, both irrelevant to Ugandan law and circumstances. The Court of Appeal properly re-evaluated the evidence and applied the correct legal principles under the Trademarks Act. The appeal to the Supreme Court was a second appeal, not a third,...

Court Disposition

appeal dismissed

Orders

  • The appeal is dismissed with costs to the respondent in the Supreme Court, Court of Appeal, High Court, and Assistant Registrar's office.
  • The orders of the Court of Appeal, including the injunction preventing registration of 'Rantac', are upheld.